Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy.

Anderson, John; Levy, Donald S; Lumry, William; Koochaki, Patricia; Lanar, Sally; Henry Li, H

Anderson, John; Levy, Donald S; Lumry, William; Koochaki, Patricia; Lanar, Sally; Henry Li, H.

Afiliação

Anderson J; Clinical Research Center of Alabama, Birmingham, AL, USA. JAnderson@alabamaallergy.com.
Levy DS; UC Irvine, Orange, CA, USA.
Lumry W; AARA Research Center, Dallas, TX, USA.
Koochaki P; ICON, Cincinnati, OH, USA.
Lanar S; ICON, Lyon, France.
Henry Li H; Institute for Asthma and Allergy, Chevy Chase, MD, USA.

Allergy Asthma Clin Immunol ; 17(1): 60, 2021 Jun 27.

Article em En | MEDLINE | ID: mdl-34176500

Palavras-chave

HAEGARDA; Health-related quality of life; Hereditary angioedema; Productivity; Qualitative research; Subcutaneous C1-inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Idioma: En Revista: Allergy Asthma Clin Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google